NFKB1 and type 2 diabetes mellitus: Additionally, it has been reported that Myrt administration reduces elevated levels of NF‐κB, TNF‐α, and IL‐1β in liver and pancreatic tissues in a rat model of Type 2 Diabetes Mellitus [22].